Immunitary Bioeconomy
Immunitary bioeconomy is a specialized branch of bioeconomics that focuses on analyzing economic models, markets, and stakeholder behaviors related to products and services derived from or targeting the immune system. This interdisciplinary field represents the convergence of immunology, biotechnology, and economic sciences.[1]
Key Areas
Key domains within immunitary bioeconomy include:
- Immunological biobanking (e.g., cord blood banking)
- Immunotherapy development and markets
- Vaccine economics
- Personalized medicine based on immune profiles
Economic and behavioral factors
Commercial models in this sector, particularly in the private segment, face significant behavioral complexities. Consumer decision-making regarding services in this field (such as private cord blood banking) is influenced by multiple factors including awareness levels, reference group influence, family disease history, price considerations, and particularly the perception of risk and benefit. A comprehensive review study demonstrates that these factors directly impact customers' behavioral intentions.[2]
References
- ↑ Brown, Nik; Machin, Laura; McLeod, Danae (2011). "Immunitary bioeconomy: The economisation of life in the international cord blood market". Social Science & Medicine. 72 (7): 1115–1122. doi:10.1016/j.socscimed.2011.01.024. PMID 21398003.
- ↑ Saraygord-Afshari, N.; Ghayem, S.; Foudazi, R.; Safa, M. (2022). "Drivers of consumers' behavioral intention toward private umbilical cord blood banking: a review". Cell and Tissue Banking. 24 (3): 651–661. doi:10.1007/s10561-022-10064-y. PMID 36534202 Check
|pmid=value (help).
This article "Immunitary Bioeconomy" is from Wikipedia. The list of its authors can be seen in its historical and/or the page Edithistory:Immunitary Bioeconomy. Articles copied from Draft Namespace on Wikipedia could be seen on the Draft Namespace of Wikipedia and not main one.
